OREXIGEN Therapeutics Overview

Life ScienceCompany

Was OREXIGEN Therapeutics formerly PE-backed?

Yes. OREXIGEN Therapeutics was formerly owned by 2 private investors.

Where is OREXIGEN Therapeutics headquartered?

OREXIGEN Therapeutics is headquartered in La Jolla, California.

What is OREXIGEN Therapeutics’ revenue?

OREXIGEN Therapeutics disclosed revenue of 89M USD for 2017 and 34M USD for 2016.

How many employees does OREXIGEN Therapeutics have?

OREXIGEN Therapeutics has 47 employees.

What sector is OREXIGEN Therapeutics in?

OREXIGEN Therapeutics is a life science company.

When was OREXIGEN Therapeutics founded?

OREXIGEN Therapeutics was founded in 2002.

OREXIGEN Therapeutics, Inc.

3344 N. Torrey Pines Court, Suite 200,
La Jolla, California 92037
United States,
(858) 875-8600
www.orexigen.com

Orexigen Therapeutics, Inc. is a bio-pharmaceutical company focuses on the treatment of obesity. The Company's lead product candidate is Contrave, which has completed Phase III clinical trials and for which a New Drug Application has been submitted and reviewed by the FDA.



Try Mergr Free — See This and 221,260+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 215K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.